Baymatob

company

About

Baymatob is a AI-guided solutions to improve health outcomes for mothers and their babies.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$4.56M
Industries
Artificial Intelligence,Health Care,Medical Device
Founded date
Jan 1, 2016
Number Of Employee
11 - 50
Operating Status
Active

Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies. The company was founded after the traumatic birth experience Dr Sarah McDonald, a mechatronic engineer with a PhD in medicine.

Oli PPH is Baymatob's first AI-guided medical product based on the Oli maternity sensor, monitoring and diagnostic platform. Oli PPH is the only product to have ever demonstrated the ability to identify women who are at higher risk of developing postpartum hemorrhage well before they give birth, allowing for early prediction and clinical actions to prevent the leading cause of preventable maternal death. Oli PPH was recently granted Breakthrough Device Designation by the U.S. Food and Drug Administration.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$4.56M
Baymatob has raised a total of $4.56M in funding over 2 rounds. Their latest funding was raised on Mar 21, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 21, 2022 Series A $4.56M 1 Future of Healthcare Fund - Australian Unity Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Baymatob is funded by 1 investors. Future of Healthcare Fund - Australian Unity are the most recent investors.
Investor Name Lead Investor Funding Round
Future of Healthcare Fund - Australian Unity Yes Series A